LAULETTA, ANTONIO
 Distribuzione geografica
Continente #
AS - Asia 595
NA - Nord America 579
EU - Europa 547
SA - Sud America 80
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.838
Nazione #
US - Stati Uniti d'America 558
IT - Italia 326
SG - Singapore 275
CN - Cina 95
HK - Hong Kong 86
BR - Brasile 65
DE - Germania 61
GB - Regno Unito 42
VN - Vietnam 40
IN - India 33
FI - Finlandia 24
JP - Giappone 13
MA - Marocco 13
RU - Federazione Russa 13
CA - Canada 11
SE - Svezia 11
BD - Bangladesh 9
ID - Indonesia 9
TR - Turchia 8
AL - Albania 7
AT - Austria 7
FR - Francia 7
NL - Olanda 7
ZA - Sudafrica 7
PL - Polonia 6
SA - Arabia Saudita 6
TG - Togo 6
EC - Ecuador 5
ES - Italia 5
KR - Corea 5
LI - Liechtenstein 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
LT - Lituania 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
CO - Colombia 3
GR - Grecia 3
IE - Irlanda 3
IQ - Iraq 3
CR - Costa Rica 2
ET - Etiopia 2
JM - Giamaica 2
KE - Kenya 2
UA - Ucraina 2
UZ - Uzbekistan 2
AO - Angola 1
AU - Australia 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
IS - Islanda 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
MZ - Mozambico 1
PA - Panama 1
PK - Pakistan 1
PS - Palestinian Territory 1
TH - Thailandia 1
TZ - Tanzania 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.838
Città #
Singapore 164
Rome 136
Ashburn 121
Hong Kong 84
Dallas 49
Los Angeles 36
Munich 30
Milan 26
Santa Clara 26
Chandler 23
Beijing 22
Hillsboro 22
New York 21
Cosenza 18
Hanoi 16
Buffalo 13
Turku 13
Casablanca 12
Tokyo 12
Fairfield 11
Redondo Beach 11
Boardman 10
Boston 10
Ho Chi Minh City 9
Barnet 8
Hefei 8
Jakarta 8
London 8
Naples 8
Frankfurt am Main 7
Johannesburg 7
Nuremberg 7
Ponzano Veneto 7
São Paulo 7
Denver 6
Lappeenranta 6
Lomé 6
Montreal 6
San Paolo di Civitate 6
Wilmington 6
Falkenstein 5
Helsinki 5
Houston 5
Lawrence 5
Palermo 5
Paris 5
Princeton 5
Seoul 5
Warsaw 5
Bari 4
Bengaluru 4
Manchester 4
Poplar 4
San Francisco 4
Seattle 4
Sofia 4
Tianjin 4
Tirana 4
Vienna 4
Brent 3
Brooklyn 3
Camden 3
Chennai 3
Chicago 3
Dublin 3
Fasano 3
Florianópolis 3
Jinan 3
Orem 3
Patna 3
Woodbridge 3
Addis Ababa 2
Ankara 2
Ariano Irpino 2
Atlanta 2
Bogotá 2
Brasília 2
Bremen 2
Bulgarograsso 2
Bussolengo 2
Cambridge 2
Cascina 2
Changsha 2
Dammam 2
Dubai 2
Fortaleza 2
Genoa 2
Grottaglie 2
Guayaquil 2
Haiphong 2
Hangzhou 2
Hayward 2
Hải Dương 2
Innsbruck 2
Jeddah 2
La Spezia 2
Melzo 2
Minneapolis 2
Moscow 2
Nairobi 2
Totale 1.185
Nome #
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv pre‐symptomatic carriers: relationships with predicted time of disease onset (PADO) 142
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up 131
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients 121
Muscle MRI in immune-mediated necrotizing myopathy (IMNM). implications for clinical management and treatment strategies 118
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study 117
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) 115
Gender effect on cardiac involvement in myotonic dystrophy type 1 106
Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation 102
High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP 101
Distal upper limb involvement in myasthenia-myositis association 100
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 94
Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open-label extension MG0004 study 87
Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause? 81
Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors 79
Management of overlapping immune-related myocarditis, myositis, and myasthenia in a young patient with advanced NSCLC: a case report 65
Nerve high-resolution ultrasound in a 2-years follow-up of radial nerve palsy related to humeral shaft fractures 65
Emergent role of complement inhibitors in myasthenic crisis: Understanding why, when and how 64
Clinical course of neurologic adverse events associated with immune checkpoint inhibitors focus on chronic toxicities 62
Refining the clinical and therapeutic spectrum of granulomatous myositis from a large cohort of patients 59
High prevalence of facioscapulohumeral muscular dystrophy (FSHD) and inflammatory myopathies association: Is there an interplay? 50
Mitochondrial pathology in inflammatory myopathies: a marker of worse clinical outcome 30
Response to letter to the editor: “Emergent role of complement inhibitors in myasthenic crisis” (CNN-D-25-2224) 17
Response to comment on: “Emergent role of complement inhibitors in myasthenic crisis – Complement for crisis, FcRn for continuity (CNN-D-25–2177)” 14
null 4
Totale 1.924
Categoria #
all - tutte 6.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.307


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 3 1 3 11 1 3
2021/202294 18 0 0 5 13 10 8 2 5 3 23 7
2022/2023139 9 19 6 19 15 25 9 10 7 2 7 11
2023/2024214 4 14 10 18 18 34 16 12 2 32 28 26
2024/2025690 16 71 34 41 40 26 23 52 90 44 52 201
2025/2026765 151 88 120 233 173 0 0 0 0 0 0 0
Totale 1.924